You are here: All Products  > Alphamab Out-Licenses HER-2 Bispecific to CSPC in $150 Million Agreement

Alphamab Out-Licenses HER-2 Bispecific to CSPC in $150 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products